Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24516013

Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 Mar 20
First author
Advani RH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Advani RH
      type
      Author
    2. name
      Horning SJ
      type
      Author
    3. name
      Hoppe RT
      type
      Author
    4. name
      Daadi S
      type
      Author
    5. name
      Allen J
      type
      Author
    6. name
      Natkunam Y
      type
      Author
    7. name
      Bartlett NL
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Advani RH
      type
      Author
    2. name
      Horning SJ
      type
      Author
    3. name
      Hoppe RT
      type
      Author
    4. name
      Daadi S
      type
      Author
    5. name
      Allen J
      type
      Author
    6. name
      Natkunam Y
      type
      Author
    7. name
      Bartlett NL
      type
      Author
    bibliography ids
    1. nci-bib-e42491990035161c1ff94963
    book metadata
    content sha256
    9f87cfb8fc969e2a7e4254088392e7de66ea8521ab83fc60787c04d08e53eba0
    document type
    citation
    dois
    1. 10.1200/JCO.2013.53.2069
    electronic publication date
    display
    2014 Feb 10
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24516013
    immutable id
    pubmed:24516013@9f87cfb8fc969e2a7e4254088392e7de66ea8521ab83fc60787c04d08e53eba0
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    9
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    912-8
    volume
    32
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24516013
      provenance
      batch id
      af10498814d931b53231
      provider
      NCBI PubMed ESummary
      record sha256
      30f16914d8cc4efef73c4350f7e46eba25fbf496194da586b5c421cbadb2b888
      response sha256
      077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
      retrieved at
      2026-09-09T23:47:00.193465+00:00
      publication date
      display
      2014 Mar 20
      precision
      day
      year
      2014
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24516013/
      title
      Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.

      Preserved source evidence · Not medical advice